封面
市場調查報告書
商品編碼
1977766

全球植物病害診斷市場規模、佔有率、趨勢及成長分析報告(2026-2034年)

Global Phytopathological Disease Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 201 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計植物病害診斷市場將從 2025 年的 30.2 億美元成長到 2034 年的 55.9 億美元,2026 年至 2034 年的複合年成長率為 7.08%。

受作物健康保護需求日益成長的推動,全球植物病害診斷市場正經歷穩定成長。早期發現植物病害對於提高農業生產力至關重要。全球糧食需求的不斷成長以及對作物損失的擔憂也促進了市場擴張。

分子診斷技術和攜帶式檢測套組的進步是成長要素。農民和農業機構正在採用快速診斷工具來防止作物大面積受損。政府促進永續農業的措施也進一步刺激了市場需求。此外,植物病理學研究的增加也促進了創新。

展望未來,人工智慧(AI)與遙感探測技術的融合有望推動市場發展。新興市場農業活動的不斷拓展將創造成長機會。各公司正致力於開發經濟高效且易於現場部署的解決方案。在全球糧食安全問題日益嚴峻的背景下,全球植物病害診斷市場預計將穩定成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球植物病害診斷市場:依類型分類

  • 市場分析、洞察與預測
  • 真菌
  • 細菌
  • 病毒
  • 植原體
  • 線蟲

第5章 全球植物病害診斷市場:依作物類型分類

  • 市場分析、洞察與預測
  • 穀類和穀類食品
  • 水果和蔬菜
  • 油籽/豆類
  • 纖維作物
  • 特色作物

第6章:全球植物病害診斷市場:依診斷方法分類

  • 市場分析、洞察與預測
  • 傳統顯微鏡
  • 分子診斷
  • 生化分析
  • 免疫學檢測
  • 遙感探測

第7章:全球植物病害診斷市場:依樣品類型分類

  • 市場分析、洞察與預測
  • 植物組織
  • 土壤
  • 空氣

第8章:全球植物病害診斷市場:依診斷目的分類

  • 市場分析、洞察與預測
  • 早期發現與診斷
  • 疾病監測
  • 風險評估
  • 研究與開發

第9章 全球植物病害診斷市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第11章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • PerkinElmer Inc
    • Abbott Laboratories
    • Zoetis Inc
    • Bruker Corporation
    • MAfA(C)Rieux NutriSciences Corporation
    • Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Thermo Fisher Scientific Inc
    • Neogen Corporation
    • Bio-Rad Laboratories Inc
    • Merck KGaA
    • Illumina Inc
    • Qiagen NV
    • Agdia Inc
簡介目錄
Product Code: VMR112113249

The Phytopathological Disease Diagnostics Market size is expected to reach USD 5.59 Billion in 2034 from USD 3.02 Billion (2025) growing at a CAGR of 7.08% during 2026-2034.

The Global Phytopathological Disease Diagnostics Market is witnessing steady growth driven by increasing need to protect crop health. Early detection of plant diseases is crucial for improving agricultural productivity. Rising global food demand and concerns about crop losses are supporting market expansion.

Key growth drivers include advancements in molecular diagnostic techniques and portable testing kits. Farmers and agricultural institutions are adopting rapid diagnostic tools to prevent widespread crop damage. Government initiatives promoting sustainable agriculture are further strengthening demand. Additionally, increasing research in plant pathology is contributing to innovation.

Looking ahead, the market is expected to benefit from integration of AI and remote sensing technologies. Emerging markets with expanding agricultural activities will create growth opportunities. Companies are focusing on cost-effective and field-deployable solutions. As global food security concerns intensify, the Global Phytopathological Disease Diagnostics Market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Fungi
  • Bacteria
  • Viruses
  • Phytoplasmas
  • Nematodes

By Crop Type

  • Cereals and Grains
  • Fruits and Vegetables
  • Oilseeds and Pulses
  • Fiber Crops
  • Specialty Crops

By Diagnostic Method

  • Traditional Microscopy
  • Molecular Diagnostics
  • Biochemical Assays
  • Immunological Assays
  • Remote Sensing

By Sample Type

  • Plant Tissue
  • Soil
  • Water
  • Air

By Purpose of Diagnostics

  • Early Detection and Diagnosis
  • Disease Monitoring
  • Risk Assessment
  • Research and Development

COMPANIES PROFILED

  • PerkinElmer Inc, Abbott Laboratories, Zoetis Inc, Bruker Corporation, Mrieux NutriSciences Corporation, HoffmannLa Roche Ltd, Danaher Corporation, Thermo Fisher Scientific Inc, Neogen Corporation, BioRad Laboratories Inc, Merck KGaA, Illumina Inc, Qiagen NV, Agdia Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Fungi Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Bacteria Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Viruses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Phytoplasmas Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Nematodes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS MARKET: BY CROP TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Crop Type
  • 5.2. Cereals and Grains Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Fruits and Vegetables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Oilseeds and Pulses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Fiber Crops Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Specialty Crops Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS MARKET: BY DIAGNOSTIC METHOD 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Diagnostic Method
  • 6.2. Traditional Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Biochemical Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Immunological Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Remote Sensing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Sample Type
  • 7.2. Plant Tissue Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Soil Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Water Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Air Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS MARKET: BY PURPOSE OF DIAGNOSTICS 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Purpose Of Diagnostics
  • 8.2. Early Detection and Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Disease Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Type
    • 9.2.2 By Crop Type
    • 9.2.3 By Diagnostic Method
    • 9.2.4 By Sample Type
    • 9.2.5 By Purpose Of Diagnostics
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Type
    • 9.3.2 By Crop Type
    • 9.3.3 By Diagnostic Method
    • 9.3.4 By Sample Type
    • 9.3.5 By Purpose Of Diagnostics
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Type
    • 9.4.2 By Crop Type
    • 9.4.3 By Diagnostic Method
    • 9.4.4 By Sample Type
    • 9.4.5 By Purpose Of Diagnostics
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Type
    • 9.5.2 By Crop Type
    • 9.5.3 By Diagnostic Method
    • 9.5.4 By Sample Type
    • 9.5.5 By Purpose Of Diagnostics
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Type
    • 9.6.2 By Crop Type
    • 9.6.3 By Diagnostic Method
    • 9.6.4 By Sample Type
    • 9.6.5 By Purpose Of Diagnostics
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 PerkinElmer Inc
    • 11.2.2 Abbott Laboratories
    • 11.2.3 Zoetis Inc
    • 11.2.4 Bruker Corporation
    • 11.2.5 MAfA(C)Rieux NutriSciences Corporation
    • 11.2.6 Hoffmann-La Roche Ltd
    • 11.2.7 Danaher Corporation
    • 11.2.8 Thermo Fisher Scientific Inc
    • 11.2.9 Neogen Corporation
    • 11.2.10 Bio-Rad Laboratories Inc
    • 11.2.11 Merck KGaA
    • 11.2.12 Illumina Inc
    • 11.2.13 Qiagen N.V
    • 11.2.14 Agdia Inc